TrialDrugs in R&D2013

The safety of besifloxacin ophthalmic suspension 0.6 % used three times daily for 7 days in the treatment of bacterial conjunctivitis.

Ranjan Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.